Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on September 22, 2025
The Sentinel Introduces Transformative Approach to Healing in British Columbia, Setting a New Standard in Integrative Care
KASLO, BC, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Sentinel, a leading wellness centre, today announced a major initiative advancing the integration of traditional healing practices with contemporary therapeutic modalities. Established by Richard Kay, …
MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- “The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. Everyone’s help is needed to pressure them …
Employers prepare for disruptive and transformative health plan changes, WTW survey finds
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Companies plan to evaluate disruptive changes to their healthcare plans as the cost of healthcare in the U.S. rises to the highest point in over two decades, according to a new survey by WTW (NASDAQ: WTW), a …
Sierra Tucson Named Arizona’s Best Addiction Treatment Center by Newsweek
TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Sierra Tucson ranked No. 1 in Newsweek’s 2025 list of the best addiction treatment centers in the state of Arizona, marking the sixth time the facility has earned a top spot in the prestigious publication’s …
Wilmington Treatment Center Listed as a Newsweek Best Addiction Treatment Center
WILMINGTON, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Wilmington Treatment Center ranked No. 1 in Newsweek’s 2025 list of the best addiction treatment centers in the state of North Carolina, marking the sixth time the facility has earned a top spot in the …
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its new Life Sciences Placement Program (LSPP) in …
Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight
New York, USA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight The thalassemia market is primarily driven by regular blood transfusions and iron chelation …
Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS
MIDDLETOWN, Conn., Sept. 22, 2025 (GLOBE NEWSWIRE) -- During September’s PCOS Awareness Month, Fairhaven Health is drawing attention to the role targeted nutrition can play in supporting women affected by polycystic ovary syndrome (PCOS) while reinforcing …
Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and …
New mobile units to drive early breast cancer detection in Alberta
EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is now being performed in two brand-new mobile units for women in rural and Indigenous communities across Alberta. These units replace aging trailers that had served the province …
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Humanitarian aid nonprofit, Human Appeal Canada, is kicking off their second annual comedy takeover tour featuring famous comedians to raise money in support of Human Appeal’s emergency appeals to deliver life- …
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong …
Angelini Pharma sigla un accordo di opzione esclusiva con Sovargen per ottenere i diritti globali di sviluppo e commercializzazione di un asset innovativo nell'ambito della salute del cervello
Angelini Pharma ottiene un'opzione esclusiva per acquisire i diritti globali di sviluppo e commercializzazione al di fuori della Repubblica di Corea, della Cina, di Hong Kong, di Macao e Taiwan di SVG1051, un’innovativa molecola sperimentale in fase …
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the brain infusion of therapeutic agents …
Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting
HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric neurology through three poster presentations and a satellite …
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase 2a clinical trials Clear regulatory …
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a …
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the …